Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    50,743.82
    +595.09 (+1.19%)
     
  • CMC Crypto 200

    1,325.68
    +48.70 (+3.81%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

Company News For Oct 4, 2019

  • Shares of Constellation Brands, Inc. STZ  dropped 6.1% after the company took an $839 million markdown in the value of its investment in Canopy Growth Corporation CGC

  • Bed Bath & Beyond Inc.’s BBBY shares rose 2.7% after the company reported better-than-expected second-quarter fiscal 2019 earnings of 34 cents per share beating the Zacks Consensus Estimate of 26 cents

  • Shares of PepsiCo, Inc. PEP rose nearly 3% as the company reported better-than-expected third-quarter earnings of $1.56 per share surpassing the Zacks Consensus Estimate of $1.50

  • Catalyst Biosciences, Inc.’s CBIO shares rose 24.6% after the company reported an update on DalcA Phase 2b trial


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Constellation Brands Inc (STZ) : Free Stock Analysis Report
 
Pepsico, Inc. (PEP) : Free Stock Analysis Report
 
Bed Bath & Beyond Inc. (BBBY) : Free Stock Analysis Report
 
Canopy Growth Corporation (CGC) : Free Stock Analysis Report
 
Catalyst Biosciences, Inc. (CBIO) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research